XML 37 R20.htm IDEA: XBRL DOCUMENT

Equity Investments	12 Months Ended
Equity Investments	Dec. 31, 2022
Equity Investment And Royalties [Abstract]
Equity Investments [Text Block]	14. Equity Investments Upon the completion of the Merger on April 22, 2022, the Company acquired Live Current's investment in warrants exercisable into 2,000,000 shares of Cell MedX Corp ("CMXC"). 1,000,000 of the warrants are exercisable at $0.50 per shares, 1,000,000 of the warrants are exercisable at $1.00 per share, and all the warrants expire January 31, 2023. On December 31, 2022, the fair value of the warrants was $0. During the year ended December 31, 2022, the Company recognized a change in the fair value of the warrant of $46,038 which is included in other income (loss) on the consolidated statement of operations.